The Filing Desk

Coya Therapeutics vs Ovid Therapeutics

Coya Therapeutics COYA · Ovid Therapeutics OVID · Pharmaceuticals

Coya Therapeutics reported revenue of $8 million in fiscal 2025, about the same as Ovid Therapeutics' $7 million in fiscal 2025. Coya Therapeutics' revenue grew 123.6% in its latest year, and Ovid Therapeutics' grew 1181.3%. Coya Therapeutics had an operating margin of -283.9%, against -585.2% at Ovid Therapeutics.

Side by side

Coya TherapeuticsOvid Therapeutics
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$8M$7M
Revenue growth123.6%1,181.3%
Revenue growth a year, last 5 years—−10.3%
Gross margin——
Operating margin−283.9%−585.2%
Net margin−267.1%−240.1%
Free cash flow—−$38M
Free cash flow margin—−528.6%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count9.8%—
Last close$2.98$2.34
P/E at the last close——
Insider trades, last 12 months—sold $29,285
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Coya TherapeuticsOvid Therapeutics
Operating margin
Percent of revenue
Coya TherapeuticsOvid Therapeutics
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Coya TherapeuticsOvid Therapeutics

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Coya Therapeutics and Ovid Therapeutics pages.